Search Results

The device indications for use are as follows: Refractory left ventricular failure Cardiogenic or Septic shock Unstable refractory angina Impending Infarction Ischemia-related ventricular arrhythmias Weaning from Cardiopulmonary bypass Support and stabilization during coronary angioplasty Intraoperative pulsatile flow generation Associated mechanical complications of acute myocardial infarction Support and stabilization of high-risk patients undergoing general surgical procedures.

The 8Fr. and 7Fr. IAB catheters consist of a dual lumen coaxial shaft design with either a 40cc (8Fr.) or 30cc (7Fr.) balloon attached to the distal end. The catheters all have a central lumen which serves as a guidewire introduction and pressure monitoring lumen. The central lumen also serves as the distal anchor for the balloon. The outer lumen terminates at the proximal end of the balloon. The area between the two lumens forms the gas shuttle area. Radiopaque markers are present at both the distal tip and proximal end of the balloon. Each IAB catheter is supplied with a balloon kit and an insertion kit. The balloon kit contains the balloon catheter, airway tubing, a male luer lock cap, a 3-way stopcock, a syringe, Kontron and/or DataScope adaptor, 6" pressure tubing with a stopcock, and 36" pressure tubing. The insertion kit contains a 6" percutaneous introducer, an introducer dilator, a vessel dilator, two 150cm floppy J guidewires (0.025") and an 18 gauge angiography needle.

The provided text is a 510(k) summary for the Bard 8Fr., 40cc. & 7Fr., 30cc Sheathless Intra-Aortic Balloon Catheters, seeking clearance from the FDA. It does not describe acceptance criteria for a device, nor a study proving the device meets acceptance criteria. Instead, it details the device, its intended use, and compares its general characteristics to predicate devices as part of the substantially equivalent argument for FDA clearance.

Therefore, I cannot extract the requested information from this document. The document confirms that biocompatibility testing and testing according to FDA's current guidelines on IAB testing were performed and "All testing was successfully completed." However, it does not provide specifics on the acceptance criteria, the detailed results or performance metrics, sample sizes, ground truth establishment, or any comparative effectiveness studies as you've requested for a medical device study showing performance against acceptance criteria.

This document is a regulatory submission, not a study report.

Ask a specific question about this device